{
    "root": "34b19a23-4595-417e-9592-fd1d69398e59",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Spironolactone",
    "value": "20250301",
    "ingredients": [
        {
            "name": "Spironolactone",
            "code": "27O7W4T232"
        },
        {
            "name": "Calcium Sulfate Dihydrate",
            "code": "4846Q921YM"
        },
        {
            "name": "Hypromellose, Unspecified",
            "code": "3NXW29V3WO"
        },
        {
            "name": "Magnesium Stearate",
            "code": "70097M6I30"
        },
        {
            "name": "Microcrystalline Cellulose 101",
            "code": "7T9FYH5QMK"
        },
        {
            "name": "Mint",
            "code": "FV98Z8GITP"
        },
        {
            "name": "Polyethylene Glycol, Unspecified",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "Povidone K30",
            "code": "U725QWY32X"
        },
        {
            "name": "Starch, Corn",
            "code": "O8232NY3SJ"
        },
        {
            "name": "Sodium Starch Glycolate Type A Potato",
            "code": "5856J3G2A2"
        },
        {
            "name": "Talc",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "Titanium Dioxide",
            "code": "15FIX9V2JP"
        }
    ],
    "indications": "spironolactone aldosterone antagonist indicated : • treatment nyha class iii-iv heart failure reduced ejection fraction increase survival , manage edema , reduce need hospitalization heart failure ( error ! hyperlink reference valid . ) . • add-on therapy treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions ( error ! hyperlink reference valid . ) . • management edema adult patients cirrhotic edema responsive fluid sodium restrictions setting nephrotic syndrome treatment underlying disease , restriction fluid sodium intake , diuretics produce inadequate response ( 1.3 ) . • treatment primary hyperaldosteronism : ( 1.4 ) short-term preoperative treatment long-term maintenance patients discrete aldosterone-producing adrenal adenomas candidates surgery patients bilateral micro macronodular adrenal hyperplasia",
    "contraindications": "• heart failure : initiate treatment 25 mg daily ( error ! hyperlink reference valid . ) . • hypertension : initiate treatment 25 100 mg daily either single divided doses ( error ! hyperlink reference valid . ) . • edema : initiate therapy hospital setting titrate slowly . recommended initial daily dose 100 mg single divided doses ( error ! hyperlink reference valid . ) . • primary hyperaldosteronism : initiate treatment 100 400 mg preparation surgery . patients unsuitable surgery lowest effective determined individual patient ( error ! hyperlink reference valid . ) .",
    "warningsAndPrecautions": "spironolactone 100 mg tablets round , white off-white , scored , convex , coated , debossed 854 bisect one side debossed “ ” side , supplied : ndc number size 82804-205-30 bottle 30 store 77°f ( 25°c ) .",
    "adverseReactions": "spironolactone contraindicated patients : • hyperkalemia •addison ’ disease •concomitant eplerenone",
    "indications_original": "Spironolactone is an aldosterone antagonist indicated for: • The treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hospitalization for heart failure ( Error! Hyperlink reference not valid. ). • Use as an add-on therapy for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions ( Error! Hyperlink reference not valid. ). • The management of edema in adult patients who are cirrhotic when edema is not responsive to fluid and sodium restrictions and in the setting of nephrotic syndrome when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics produce an inadequate response ( 1.3 ). • Treatment of primary hyperaldosteronism for: ( 1.4 ) o Short-term preoperative treatment o Long-term maintenance for patients with discrete aldosterone-producing adrenal adenomas who are not candidates for surgery and patients with bilateral micro or macronodular adrenal hyperplasia",
    "contraindications_original": "• Heart Failure: Initiate treatment at 25 mg once daily ( Error! Hyperlink reference not valid. ). • Hypertension: Initiate treatment at 25 to 100 mg daily in either single or divided doses ( Error! Hyperlink reference not valid. ). • Edema:  Initiate therapy in a hospital setting and titrate slowly.  The recommended initial daily dose is 100 mg in single or divided doses ( Error! Hyperlink reference not valid. ). • Primary hyperaldosteronism:  Initiate treatment at 100 to 400 mg in preparation for surgery.  In patients unsuitable for surgery use the lowest effective dosage determined for the individual patient ( Error! Hyperlink reference not valid. ).",
    "warningsAndPrecautions_original": "Spironolactone 100 mg tablets are round, white to off-white, scored, convex, coated, debossed with 854 above of the bisect on one side and debossed with “O” on the other side, supplied as:\n                  \n                     \n                     \n                     \n                        \n                           \n                              NDC Number\n                           \n                           \n                              Size\n                           \n                        \n                        \n                           \n                              82804-205-30\n                           \n                           \n                              bottle of 30\n                           \n                        \n                        \n                           \n                           \n                        \n                     \n                  \n                  Store below 77°F (25°C).",
    "adverseReactions_original": "Spironolactone is contraindicated in the patients with:\n                  \n                     \n                        •\n                        Hyperkalemia\n                     \n                     \n                        •Addison’s disease\n                     \n                        •Concomitant use of eplerenone"
}